TBXT and cancer: KEGG results showed that the "PI3K-Akt signaling pathway", "mTOR signaling pathway", "PD-L1 expression and PD-1 checkpoint pathway in cancer" and "T cell receptor signaling pathway" were significantly enriched (Figure 7B).